LGALS3 and breast carcinoma: Concerning a value of Gal-3 of 9.2 ng/mL, similar cut-off was also achieved in different diseases (level ≥10.3 ng/mL as an independent prognostic marker in pancreatobiliary cancer [30], 10.53 ng/mL in patients with atrial fibrillation [31] or a cut-off value of Gal-3 ≥3.17 ng/mL to predict breast cancer [32]).